| http://www.w3.org/ns/prov#value | - Kiuchi, K., Matsuoka, M., Wu, J.C., Lima e Silva, R., Kengatharan, M., Verghese, M., Ueno, S., Yokoi, K., Khu, N.H., Cooke, J.P., Campochiaro, P.A.; Invest Ophthalmol Vis Sci. 2008 Apr.Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration.
|
